Mumbai, Sep 3 (TIWN) Reliance Strategic Business Ventures Limited (RSBVL), a wholly-owned subsidiary of Reliance Industries (RIL), has acquired over 2.28 crore equity shares stake in Strand Life Sciences Pvt Ltd for Rs 393 crore.

A further investment of up to Rs 160 crore is expected to be completed by March 2023, it said.  The total investment will translate into 80.3 per cent of equity share capital in Strand on a fully-diluted basis.  Incorporated in India on October 6, 2000, Strand is a pioneer of genomic testing in the country with bioinformatics software and clinical research solutions to healthcare providers including clinicians, hospitals, medical devices manufacturers and pharmaceutical companies.